Monoclonal Immunoglobulin-Associated Renal Lesions in Patients with Newly Diagnosed Multiple Myeloma: A Report from a Single Center

References

• Rollig C, Knop S, Bornhauser M. Multiple myeloma. Lancet. 2015;385(9983):2197–2208. doi:10.1016/S0140-6736(14)60493-125540889
   PubMed Web of Science ®Google Scholar
• Eleutherakis-Papaiakovou V, Bamias A, Gika D, et al. Renal failure in multiple myeloma: incidence, correlations, and prognostic significance. Leuk Lymphoma. 2007;48(2):337–341. doi:10.1080/1042819060112660217325894
   PubMed Web of Science ®Google Scholar
• Dimopoulos MA, Kastritis E, Rosinol L, Blade J, Ludwig H. Pathogenesis and treatment of renal failure in multiple myeloma. Leukemia. 2008;22(8):1485–1493. doi:10.1038/leu.2008.13118528426
   PubMed Web of Science ®Google Scholar
• Motwani SS, Herlitz L, Monga D, Jhaveri KD, Lam AQ. Paraprotein-related kidney disease: glomerular diseases associated with paraproteinemias. Clin j Am Society Nephrol. 2016;11(12):2260–2272. doi:10.2215/CJN.02980316
   PubMed Web of Science ®Google Scholar
• Lin ZS, Qin AB, Wang SX, et al. A non-invasive differential diagnostic model for light chain cast nephropathy in newly diagnosed multiple myeloma patients with renal involvement: a multicenter study. J Nephrol. 2021. doi:10.1007/s40620-020-00926-7
   Web of Science ®Google Scholar
• Sethi S, Rajkumar SV, D’Agati VD. The complexity and heterogeneity of monoclonal immunoglobulin-associated renal diseases. J Am Society Nephrol. 2018;29(7):1810–1823. doi:10.1681/ASN.2017121319
   PubMed Web of Science ®Google Scholar
• Nasr SH, Valeri AM, Sethi S, et al. Clinicopathologic correlations in multiple myeloma: a case series of 190 patients with kidney biopsies. Am j Kidney Dis. 2012;59(6):786–794. doi:10.1053/j.ajkd.2011.12.02822417785
   PubMed Web of Science ®Google Scholar
• Nasr SH, Valeri AM, Cornell LD, et al. Renal monoclonal immunoglobulin deposition disease: a report of 64 patients from a single institution. Clin j Am Society Nephrol. 2012;7(2):231–239. doi:10.2215/CJN.08640811
   PubMed Web of Science ®Google Scholar
• Zand L, Nasr SH, Gertz MA, et al. Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both. Leuk Lymphoma. 2015;56(12):3357–3364. doi:10.3109/10428194.2015.104001125860232
   PubMed Web of Science ®Google Scholar
• Lin J, Markowitz GS, Valeri AM, et al. Renal monoclonal immunoglobulin deposition disease: the disease spectrum. J Am Society Nephrol. 2001;12(7):1482–1492. doi:10.1681/ASN.V1271482
   PubMed Web of Science ®Google Scholar
• Dimopoulos MA, Sonneveld P, Leung N, et al. International myeloma working group recommendations for the diagnosis and management of myeloma-related renal impairment. J clin oncol. 2016;34(13):1544–1557. doi:10.1200/JCO.2015.65.004426976420
   PubMed Web of Science ®Google Scholar
• Ecotiere L, Thierry A, Debiais-Delpech C, et al. Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients. Nephrol Dial Transplant. 2016;31(1):64–72. doi:10.1093/ndt/gfv28326289418
   PubMed Web of Science ®Google Scholar
• Royal V, Leung N, Troyanov S, et al. Clinicopathologic predictors of renal outcomes in light chain cast nephropathy: a multicenter retrospective study. Blood. 2020;135(21):1833–1846. doi:10.1182/blood.201900380732160635
   PubMed Web of Science ®Google Scholar
• Durie BG, Kyle RA, Belch A, et al. Myeloma management guidelines: a consensus report from the Scientific Advisors of the International Myeloma Foundation. Hematol J. 2003;4(6):379–398. doi:10.1038/sj.thj.620031214671610
   PubMedGoogle Scholar
• Iványi B. Frequency of light chain deposition nephropathy relative to renal amyloidosis and Bence Jones cast nephropathy in a necropsy study of patients with myeloma. Arch Pathol Lab Med. 1990;114(9):986–987.2117910
   PubMed Web of Science ®Google Scholar
• Mohan M, Buros A, Mathur P, et al. Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease. Am J Hematol. 2017;92(8):739–745. doi:10.1002/ajh.2475628383130
   PubMed Web of Science ®Google Scholar
• Hutchison CA, Cockwell P, Stringer S, et al. Early reduction of serum-free light chains associates with renal recovery in myeloma kidney. J Am Society Nephrol. 2011;22(6):1129–1136. doi:10.1681/ASN.2010080857
   PubMed Web of Science ®Google Scholar
• Montseny JJ, Kleinknecht D, Meyrier A, et al. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies. Nephrol Dial Transplant. 1998;13(6):1438–1445. doi:10.1093/ndt/13.6.14389641173
   PubMed Web of Science ®Google Scholar
• Gavriatopoulou M, Terpos E, Kastritis E, Dimopoulos MA. Current treatments for renal failure due to multiple myeloma. Expert Opin Pharmacother. 2016;17(16):2165–2177. doi:10.1080/14656566.2016.123691527646819
   PubMed Web of Science ®Google Scholar
• Decourt A, Gondouin B, Delaroziere JC, et al. Trends in survival and renal recovery in patients with multiple myeloma or light-chain amyloidosis on chronic dialysis. Clin j Am Society Nephrol. 2016;11(3):431–441. doi:10.2215/CJN.06290615
   PubMed Web of Science ®Google Scholar
• Dimopoulos MA, Roussou M, Gavriatopoulou M, et al. Outcomes of newly diagnosed myeloma patients requiring dialysis: renal recovery, importance of rapid response and survival benefit. Blood Cancer J. 2017;7(6):e571. doi:10.1038/bcj.2017.4928622304
   PubMed Web of Science ®Google Scholar
• Cobb J, Plantinga L, Luthi JC, et al. Pre-ESRD care and mortality in incident ESRD patients with multiple myeloma. Am J Clin Oncol. 2018;41(4):367–370. doi:10.1097/COC.000000000000027526886949
   PubMed Web of Science ®Google Scholar
• Sørrig R, Klausen TW, Salomo M, Vangsted A, Gimsing P. Risk factors for infections in newly diagnosed Multiple Myeloma patients: a Danish retrospective nationwide cohort study. Eur J Haematol. 2019;102(2):182–190. doi:10.1111/ejh.1319030485563
   PubMed Web of Science ®Google Scholar
• Ricardo AC, Yang W, Sha D, et al. Sex-related disparities in CKD Progression. J Am Society Nephrol. 2019;30(1):137–146. doi:10.1681/ASN.2018030296
   PubMed Web of Science ®Google Scholar
• Lu J, Lu J, Chen W, et al. Clinical features and treatment outcome in newly diagnosed Chinese patients with multiple myeloma: results of a multicenter analysis. Blood Cancer J. 2014;4:e239. doi:10.1038/bcj.2014.5525127393
   PubMed Web of Science ®Google Scholar